Point/Counterpoint: The Case for AstraZeneca

Freedom ETF Bucks Mainstream to Bet on Human Rights & Long-Term Growth

VIEW IN BROWSER

📚 Weekend Reads | Sunday, Nov 29, 2020

Point/Counterpoint: The Case for AstraZeneca

AstraZeneca PLC (LON:AZN) is in a race to develop an effective Covid-19 vaccine, but that's not it's only goal. It's really known as a global leader in cancer treatments, winning a number of drug approvals in recent years by regulators around the world. Earlier this week, the U.K.-based drug maker said late-stage trials of its Covid-19 vaccine showed 90% efficacy, but it quickly had to acknowledge flaws in the data. Investing.com's Geoffrey Smith and explains why this rare misstep won't cause lasting damage, while Peter Nurse says the fall-out has real reputational risks that will weigh on valuation. This is Point/Counterpoint.

Read Full Article

Most Popular Analysis

Freedom ETF Bucks Mainstream to Bet on Human Rights & Long-Term Growth By Investing.com What kind of an emerging markets index doesn't include China or Russia?

2 ETFs For Digitalization Trends By Tezcan Gecgil/Investing.com 2020 has become the year when digital trends have entered our lives faster than ever before. For instance, due to the pandemic, robust digital infrastructure and remote work arrangements have become...

How Much Higher Can Tesla Stock Go? By Haris Anwar/Investing.com The shares of Tesla (NASDAQ:TSLA) are on fire these days. After rallying strongly in a broad-based market recovery since March, they have gained another 40% in just the past 10 days. That upswing is...

3 Stocks Likely To Benefit From A Vaccine-Enabled Return To Normalcy By Jesse Cohen/Investing.com Positive news on COVID-19 vaccine progress has sparked a massive rally on Wall Street this month, with both the Dow Jones Industrial Average and S&P 500 notching a series of new record highs in...

Hot Housing Stocks May Be Cooling Fast By Michael Kramer This article was written exclusively for Investing.comThe PHLX Housing Index has stalled out in recent months, up just over 1% since Sept. 1. However, the past couple of months have been volatile,...

Show More Analysis »

Weekly Comic

Stocks Rally To New Records As Markets Cheer Yellen Pick For Treasury

Show More Comics »

Download Our Award Winning Apps

Follow us:

To ensure proper delivery of Investing.com Newsletters to your inbox, please add newsletter@investingmail.com to your safe sender list.

Disclaimer: Fusion Media or anyone involved with Fusion Media will not accept any liability for any trading loss or damage as a result of reliance on the information contained within this email including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Fusion Media would like to remind you that the data contained in this email is neither necessarily real-time nor accurate. All stock prices, Indexes, Futures, buy/sell Signals and Forex prices are indicative and not appropriate for trading purposes; furthermore they are not provided by an exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price. Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. This is a newsletter from Investing.com © 2007-2020 Fusion Media Limited. All Rights Reserved 7 Florinis Street, Greg Tower 6th Floor Nicosia 1065 Cyprus Terms And Conditions   |   Privacy Policy   |   Manage your e-mail preferences   |   Unsubscribe This email was sent to o354397655@gmail.com